This Wednesday November 3, the WHO has announced they have emergency approved a brand-new Covid vaccine, Covaxin, developed by Indian biotech Bharat Biotech. According to the World Health Organization, the vaccine is 78% effective against the virus, requiring two injections four weeks apart.